2007/09 - 2011/07，華南農(nóng)業(yè)大學(xué)，生物化學(xué)與分子生物學(xué)，理學(xué)學(xué)士
2011/09 - 2014/07，中國科學(xué)院大學(xué)，生物工程，工程碩士
2014/09 - 2017/07，中國科學(xué)院大學(xué)，細(xì)胞生物學(xué)，理學(xué)博士
2017/07 - 2020/04, 中國科學(xué)院廣州生物醫(yī)藥與健康研究院，助理研究員
2020/05 - 至今，中國科學(xué)院廣州生物醫(yī)藥與健康研究院，副研究員
干細(xì)胞命運(yùn)的代謝調(diào)控
線粒體糖脂代謝-表觀遺傳互作機(jī)制
非經(jīng)典編碼區(qū)翻譯調(diào)控代謝與細(xì)胞命運(yùn)
國家自然科學(xué)基金-面上項(xiàng)目（2020年，2023年），項(xiàng)目負(fù)責(zé)人
國家自然科學(xué)基金-青年科學(xué)基金項(xiàng)目（2019年），項(xiàng)目負(fù)責(zé)人
廣東省自然科學(xué)基金-面上項(xiàng)目（2020年，2022年），項(xiàng)目負(fù)責(zé)人
廣州市基礎(chǔ)研究計(jì)劃（2020年，2024年），項(xiàng)目負(fù)責(zé)人
國家重點(diǎn)研發(fā)計(jì)劃-干細(xì)胞及轉(zhuǎn)化研究重點(diǎn)專項(xiàng)（2018年），項(xiàng)目骨干
中國科學(xué)院青年創(chuàng)新促進(jìn)會(huì)會(huì)員
廣東省精準(zhǔn)醫(yī)學(xué)應(yīng)用學(xué)會(huì)干細(xì)胞與再生醫(yī)學(xué)分會(huì)委員
廣東省呼吸與健康學(xué)會(huì)干細(xì)胞與再生醫(yī)學(xué)專委會(huì)委員
Life Medicine青年編委
?
1. Liao R#, Wu Y#, Qin L, Jiang Z, Gou S, Zhou L, Hong Q, Li Y, Shi J, Yao Y, Lai L, Li Y, Liu P, Thiery JP, Qin D, Graf T, Liu X*, Li P*. BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells. EMBO Journal, 2023, 42(21), e113448.
2. Li L#*, Sun S#, Wu Y#, Lu J#, He J, Chen K, Chan WY, Liu X*. Lactate and protein lactylation: the ugly duckling of energy as the sculpture artist of proteins. Science Bulletin, 2023, 68(21), 2510-2514. (Cover)
3. Wu Y#, Chen K#, Li L#, Hao Z#, Wang T, Liu Y, Xing G, Liu Z, Li H, Yuan H, Lu J, Zhang C, Zhang J, Zhao D, Wang J, Nie J, Ye D, Pan G, Chan WY, Liu X*. Plin2-mediated lipid droplet mobilization accelerates exit from pluripotency by lipidomic remodeling and histone acetylation. Cell Death & Differentiation, 2022, 29(11), 2312-2331. (CDD Press Readers’ Choice)
4. Wu Y#, Liu Y#, Hao Z, Liu X*. NAD+?is critical for maintaining acetyl-CoA and H3K27ac in embryonic stem cells by Sirt1-dependent deacetylation of AceCS1. Life Medicine,?2022, 1(3), 401-405. (Most Picked Paper Award 2022)
5. Li L#, Chen K#, Wu Y#, Xiang G, Liu X*. Epigenome-Metabolome-Epigenome signaling cascade in cell biological processes. Journal of Genetics and Genomics, 2022, 49(4), 279-286.
6. Li L#, Chen K#, Wang T#, Wu Y#, Xing G, Chen M, Hao Z, Zhang C, Zhang J, Ma B, Liu Z, Yuan H, Liu Z, Long Q, Zhou Y, Qi J, Zhao D, Gao M, Pei D, Nie J, Ye D, Pan G, Liu X*. Glis1 facilitates induction of pluripotency via an epigenome-metabolome-epigenome signalling cascade. Nature Metabolism,?2020,?2(9), 882-892.
7. Wu Y, Chen K, Xiang G, Ying Z, Liu X*. Organelle remodeling during the acquistion and loss of pluripotency. Science Foundation in China,?2020,?28(1), 47-55. (Cover)
8. Wu Y#, Chen K#, Xing G, Li L, Ma B, Hu Z, Duan L, Liu X*. Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition. Science Advances,?2019, 5(11), eaax7525.
9. Wu Y#, Chen K#, Liu X, Huang L, Zhao D, Li L, Gao M, Pei D, Wang C, Liu X*. (2016). Srebp-1 interacts with c-Myc to enhance somatic cell reprogramming. Stem Cells, 34(1), 83-92.
